-
EP3417877
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3417877
| EP3417877 - COMPLEX CAPABLE OF INHIBITING GENETIC FUNCTION IN EXOSOME, AND CANCER PROLIFERATION AND/OR METASTASIS SUPPRESSOR [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 12.08.2021 Database last updated on 12.06.2024 | |
| Former | Request for examination was made Status updated on 23.11.2018 | ||
| Former | The international publication has been made Status updated on 01.09.2017 | Most recent event Tooltip | 05.04.2024 | New entry: Additional fee for renewal fee: despatch of communication + time limit | Applicant(s) | For all designated states Kyoto University 36-1, Yoshida-honmachi Sakyo-ku Kyoto-shi, Kyoto 606-8501 / JP | For all designated states Kyoto Pharmaceutical University 5 Misasagi-Nakauchi-cho Yamashina-ku Kyoto-shi, Kyoto 607-8414 / JP | [2018/52] | Inventor(s) | 01 /
YAMAYOSHI, Asako c/o Kyoto University 36-1 Yoshida-honmachi Sakyo-ku Kyoto-shi Kyoto 606-8501 / JP | 02 /
MURAKAMI, Akira c/o National University Corporation Kyoto Institute of Technology 1 Matsugasaki Hashikami-cho Sakyo-ku Kyoto-shi Kyoto 606-8585 / JP | 03 /
ASHIHARA, Eishi c/o Kyoto Pharmaceutical University 5 Misasagi-Nakauchi-cho Yamashina-ku Kyoto-shi Kyoto 607-8414 / JP | 04 /
KOBORI, Akio c/o National University Corporation Kyoto Institute of Technology 1 Matsugasaki Hashikami-cho Sakyo-ku Kyoto-shi Kyoto 606-8585 / JP | [2018/52] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2018/52] | Application number, filing date | 17753337.9 | 17.02.2017 | [2018/52] | WO2017JP05994 | Priority number, date | JP20160028924 | 18.02.2016 Original published format: JP 2016028924 | [2018/52] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017142083 | Date: | 24.08.2017 | Language: | JA | [2017/34] | Type: | A1 Application with search report | No.: | EP3417877 | Date: | 26.12.2018 | Language: | EN | [2018/52] | Search report(s) | International search report - published on: | JP | 24.08.2017 | (Supplementary) European search report - dispatched on: | EP | 30.08.2019 | Classification | IPC: | A61K47/64, A61K47/68, A61K39/395, A61K31/7105, A61K48/00, A61P35/00, A61P35/04, C07K16/28, A61K39/00, C12N15/87, C12N15/11, C12N15/113 | [2019/40] | CPC: |
A61K31/7105 (EP,CN);
A61K47/6849 (EP,CN,US);
A61K31/713 (CN);
A61K47/549 (US);
A61K47/6455 (EP,US);
A61K47/6883 (EP,CN,US);
A61P35/00 (EP,CN,US);
A61P35/04 (CN);
C07K16/2803 (EP);
C07K16/2896 (EP,US);
C12N15/111 (EP);
C12N15/113 (EP,US);
C12N15/87 (EP);
A61K2039/505 (EP,US);
C07K2317/77 (EP,US);
| C-Set: |
A61K31/7105, A61K2300/00 (EP)
|
| Former IPC [2018/52] | A61K39/395, A61K31/7105, A61K48/00, A61P35/00, A61P35/04 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/52] | Title | German: | ZUR HEMMUNG DER GENETISCHEN FUNKTION IN EXOSOM FÄHIGER KOMPLEX UND KREBSPROLIFERATIONS- UND/ODER METASTASESUPPRESSOR | [2018/52] | English: | COMPLEX CAPABLE OF INHIBITING GENETIC FUNCTION IN EXOSOME, AND CANCER PROLIFERATION AND/OR METASTASIS SUPPRESSOR | [2018/52] | French: | COMPLEXE CAPABLE D'INHIBER LA FONCTION GÉNÉTIQUE DANS UN EXOSOME, ET SUPPRESSEUR DE LA PROLIFÉRATION ET/OU DE LA MÉTASTASE CANCÉREUSES | [2018/52] | Entry into regional phase | 14.09.2018 | Translation filed | 14.09.2018 | National basic fee paid | 14.09.2018 | Search fee paid | 14.09.2018 | Designation fee(s) paid | 14.09.2018 | Examination fee paid | Examination procedure | deleted | Date on which the examining division has become responsible | 14.09.2018 | Examination requested [2018/52] | 17.03.2020 | Amendment by applicant (claims and/or description) | 11.08.2021 | Despatch of a communication from the examining division (Time limit: M04) | 20.12.2021 | Reply to a communication from the examining division | Fees paid | Renewal fee | 18.02.2019 | Renewal fee patent year 03 | 21.02.2020 | Renewal fee patent year 04 | 16.02.2021 | Renewal fee patent year 05 | 22.02.2022 | Renewal fee patent year 06 | 09.02.2023 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 29.02.2024 | 08 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]WO2012178173 (CT SE LLC [US], et al) [X] 1,2,11,12 * examples 2,3,8 * [I] 1-6,8,11,12; | [XI] - SWEENY L ET AL, "A novel extracellular drug conjugate significantly inhibits head and neck squamous cell carcinoma", ORAL ONCOLOGY, (20131001), vol. 49, no. 10, doi:10.1016/j.oraloncology.2013.07.006, ISSN 1368-8375, pages 991 - 997, XP055152770 [X] 1,2,11,12 * abstract * * page 992, section "Reagents" * * figures 1-5 * [I] 1-6,8,11,12 DOI: http://dx.doi.org/10.1016/j.oraloncology.2013.07.006 | [Y] - KRICHEVSKY AM ET AL, "miR-21: a small multi-faceted RNA", JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, (20081016), vol. 13, no. 1, doi:10.1111/j.1582-4934.2008.00556.x, ISSN 1582-1838, pages 39 - 53, XP055045933 [Y] 7,9,10 * abstract * * page 49, section "Potential therapeutic target" * DOI: http://dx.doi.org/10.1111/j.1582-4934.2008.00556.x | [YA] - PEER D ET AL, "Special delivery: targeted therapy with small RNAs", GENE THERAPY, GB, (20110414), vol. 18, no. 12, doi:10.1038/gt.2011.56, ISSN 0969-7128, pages 1127 - 1133, XP055614129 [Y] 7,9,10 * figure 1 * [A] 1-6,8,11,12 DOI: http://dx.doi.org/10.1038/gt.2011.56 | International search | [A]WO2013099925 (SHIONOGI & CO [JP]) [A] 1-12 * , paragraph [0001] & US 2015/0010913 A1 paragraph [0001] & EP 2803673 A1 & CA 2860163 A & KR 10-2014-0107615 A & CN 104302667 A *; | [A]WO2014167969 (SHIONOGI & CO [JP], et al) [A] 1-12 * , paragraph [0001] & US 2016/0047812 A paragraph [0001] & EP 2985605 A1 & CA 2907606 A & CN 105074468 A *; | [A] - XIONG B et al., "MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells", International Journal of Oncology, (20130000), vol. 42, no. 1, ISSN 1019-6439, pages 219 - 228, XP055410573 [A] 1-12 * , particularly, page 219, 'Abstract' * DOI: http://dx.doi.org/10.3892/ijo.2012.1707 | [A] - FIORI ME et al., "Antitumor effect of miR-197 targeting in p53 wild-type lung cancer", Cell Death and Differentiation, (20140000), vol. 21, no. 5, ISSN 1350-9047, pages 774 - 782, XP055410574 [A] 1-12 * , particularly, page 774, summary * DOI: http://dx.doi.org/10.1038/cdd.2014.6 |